Assertio (ASRT)

• Market cap: $73.2M
• 1 day: 0.01%
• 5 days: 0.07%
• 1 month: -14.17%
• 3 months: 5.03%
• 6 months: 23.24%
• Year to date: -10.54%
• 1 year: -24.7%
• 5 years: -51.56%
• 10 years: -99.05%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Employees: 30